{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:58:55Z","timestamp":1781236735543,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejpb.2026.115110","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:29:49Z","timestamp":1778945389000},"page":"115110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The VitraCell: A new in vitro test setup for intravitreal dosage forms"],"prefix":"10.1016","volume":"225","author":[{"given":"Felix","family":"Reichel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Auel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2868-8754","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Klinken-Uth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-545X","authenticated-orcid":false,"given":"Anne","family":"Seidlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115110_b0005","series-title":"The principles of humane experimental technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.ejpb.2026.115110_b0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s42977-020-00050-4","article-title":"Biologia futura: Animal testing in drug development \u2014 the past, the present and the future","volume":"71","author":"S\u00e1ntha","year":"2020","journal-title":"Biol. Futura"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115110_b0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archophthalmol.2009.58","article-title":"Forecasting age-related macular degeneration through the year 2050 - the potential impact of new treatments","volume":"127","author":"Rein","year":"2009","journal-title":"Arch. Ophthalmol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115110_b0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/17425247.2021.1846518","article-title":"Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy","volume":"18","author":"Sharma","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115110_b0025","doi-asserted-by":"crossref","unstructured":"Vision Loss Expert Group of the Global Burden of Disease Study & the GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by age-related macular degeneration: A meta-analysis from 2000 to 2020. Eye 2024. 38, 2070 \u2013 2082. https:\/\/doi.org\/10.1038\/s41433-024-03050-z.","DOI":"10.1038\/s41433-024-03050-z"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115110_b0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.9.1.2","article-title":"In vivo measurement of the human vitreous chamber volume using computed tomography imaging of 100 eyes","volume":"9","author":"Azhdam","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115110_b0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1350-9462(99)00016-6","article-title":"Structural macromolecules and supramolecular organisation of the vitreous gel","volume":"19","author":"Bishop","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2026.115110_b0040","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/eye.2008.21","article-title":"Adult vitreous structure and postnatal changes","volume":"22","author":"Le Goff","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.ejpb.2026.115110_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107156","article-title":"Rheological and physicochemical optimization of hydrogels as potential vitreous body substitutes for in vitro release testing","volume":"212","author":"Reichel","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115110_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2026.107473","article-title":"In vitro analysis of triamcinolone acetonide dissolution and diffusion in vitreous substitutes","volume":"219","author":"Reichel","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115110_b0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02463495","article-title":"Flow and diffusion in the vitreous body of the eye","volume":"37","author":"Fatt","year":"1975","journal-title":"Bull. Math. Biol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115110_b0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1023\/A:1007517912927","article-title":"Permeability and diffusion in vitreous humor: Implications for drug delivery","volume":"17","author":"Xu","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115110_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2020.103860","article-title":"Flow dynamics of vitreous humour during saccadic eye movements","volume":"110","author":"Silva","year":"2020","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.ejpb.2026.115110_b0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41433-018-0231-z","article-title":"Pressure and velocity in intraocular and subarachnoid space fluid chambers: an inseparable couple","volume":"33","author":"Killer","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.ejpb.2026.115110_b0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"The Open Ophthalmology Journal"},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2026.115110_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1748-1716.1951.tb00755.x","article-title":"A method for determining the rate of plasma flow through the secretory part of the ciliary body","volume":"22","author":"Linn\u00e9r","year":"1951","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejpb.2026.115110_b0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2019.08.008","article-title":"Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation","volume":"143","author":"Ramsay","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115110_b0090","first-page":"58","article-title":"Blood flow in the normal human retina","volume":"30","author":"Feke","year":"1989","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115110_b0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/nbm.1564","article-title":"Blood flow quantification of the human retina with MRI","volume":"24","author":"Maleki","year":"2011","journal-title":"NMR Biomed."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115110_b0100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0003319794045006032","article-title":"Effects of pentoxifylline on choroidal blood flow in nonproliferative diabetic retinopathy","volume":"45","author":"Sebag","year":"1994","journal-title":"Angiology"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115110_b0105","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1167\/iovs.11-9384","article-title":"Blood flow MRI of the human retina\/choroid during rest and isometric exercise","volume":"53","author":"Zhang","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115110_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.8.6.1","article-title":"Influence of charge, hydrophobicity, and size on vitreous pharmacokinetics of large molecules","volume":"8","author":"Crowell","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115110_b0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0025-5564(94)90018-3","article-title":"Pharmacokinetic model of intravitreal drug injection","volume":"123","author":"Tojo","year":"1994","journal-title":"Math. Biosci."},{"key":"10.1016\/j.ejpb.2026.115110_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106603","article-title":"Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues","volume":"191","author":"Hammid","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115110_b0125","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/acs.molpharmaceut.8b00038","article-title":"Binding of small molecule drugs to porcine vitreous humor","volume":"15","author":"Rimpel\u00e4","year":"2018","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115110_b0130","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/jps.24480","article-title":"The PK-Eye: a novel in vitro ocular flow model for use in preclinical drug development","volume":"104","author":"Awwad","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115110_b0135","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/pharmaceutics13091394","article-title":"The EyeFlowCell: Development of a 3d-printed dissolution test setup for intravitreal dosage forms","volume":"13","author":"Auel","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115110_b0140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jps.23808","article-title":"Simulation of drug distribution in the vitreous body after local drug application into intact vitreous body and in progress of posterior vitreous detachment","volume":"103","author":"Loch","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115110_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113823","article-title":"Novel in vitro model for intravitreal drug dissolution and release studies of small molecules and their long-acting formulations","volume":"383","author":"Sorsa","year":"2025","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115110_b0150","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2004.05.025","article-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial","volume":"111","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115110_b0155","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archopht.1991.01080080087035","article-title":"Effect of temperature on electroretinograph readings during closed vitrectomy in humans","volume":"109","author":"Horiguchi","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejpb.2026.115110_b0160","unstructured":"U. S. Food and Drug Administration. Dissolution methods triamcinolone acetonide. 2018 (Last Accessed: 01.08.2025). https:\/\/www.accessdata.fda.gov\/scripts\/cder\/dissolution\/dsp_SearchResults.cfm."},{"key":"10.1016\/j.ejpb.2026.115110_b0165","unstructured":"AbbVie. Ozurdex\u00ae 700 \u00b5g intravitreal implant with applicator. Technical Information 2025."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115110_b0170","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/00319104.2019.1611827","article-title":"Solubility of acetaminophen in 1-propanol + water mixtures at T = 293.2\u2013313.2 K","volume":"58","author":"Pourkarim","year":"2020","journal-title":"Phys. Chem. Liq."},{"issue":"114708","key":"10.1016\/j.ejpb.2026.115110_b0175","article-title":"Solubility study of acetaminophen in the mixtures of acetonitrile and water at different temperatures","volume":"324","author":"Rahimpour","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2026.115110_b0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molliq.2014.08.033","article-title":"Thermodynamic studies on solubility and protonation constant of acetaminophen at different ionic strengths and various temperatures","volume":"199","author":"Chahiyan","year":"2014","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2026.115110_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105394","article-title":"A case study to investigate the influence of extrusion temperature, 3D printing parameters and the use of antioxidants on the degradation of dexamethasone","volume":"92","author":"Krause","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115110_b0190","unstructured":"Caesar&Loretz. Triamcinolone acetonide. Safety Data Sheet 2023."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115110_b0195","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10973-006-8006-3","article-title":"Thermal stability of paracetamol and its pre-formulates obtained by spray drying","volume":"88","author":"Medeiros","year":"2007","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejpb.2026.115110_b0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejpb.2020.01.008","article-title":"Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations","volume":"148","author":"Thakur","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115110_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108006","article-title":"Relationship between rheological properties and transverse relaxation time (T2) of artificial and porcine vitreous humour","volume":"194","author":"Thakur","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115110_b0210","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3390\/pharmaceutics15051444","article-title":"Real-time monitoring platform for ocular drug delivery","volume":"15","author":"Awwad","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115110_b0215","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/pharmaceutics14061267","article-title":"Effects of flow hydrodynamics and eye movements on intraocular drug clearance","volume":"14","author":"Velentza-Almpani","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115110_b0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2017.02.047","article-title":"Sustained release ophthalmic dexamethasone: In vitro in vivo correlations derived from the PK-Eye","volume":"522","author":"Awwad","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115110_b0225","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","article-title":"In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye","volume":"126","author":"Peynshaert","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115110_b0230","article-title":"Stability of dexamethasone during hot-melt extrusion of filaments based on Eudragit\u00ae RS, ethyl cellulose and polyethylene oxide","volume":"8","author":"Domsta","year":"2024","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115110_b0235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jop.2012.0138","article-title":"The vitreous humor as a barrier to nanoparticle distribution","volume":"29","author":"Mains","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115110_b0240","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.preteyeres.2010.04.003","article-title":"Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics","volume":"29","author":"Laude","year":"2010","journal-title":"Prog. Retin. Eye Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:28:20Z","timestamp":1781234900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"alternative-id":["S0939641126001311"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115110","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The VitraCell: A new in vitro test setup for intravitreal dosage forms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115110"}}